» Articles » PMID: 31987065

Neurological Involvement in Glycogen Storage Disease Type IXa Due to Mutation

Overview
Specialty Neurology
Date 2020 Jan 29
PMID 31987065
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Glycogen storage diseases (GSDs) result from the deficiency of enzymes involved in glycogen synthesis and breakdown into glucose. Mutations in the gene PHKA2 encoding phosphorylase kinase regulatory subunit alpha 2 have been linked to GSD type IXa. We describe a family with two adult brothers with neonatal hepatosplenomegaly and later onset of hearing loss, cognitive impairment, and cerebellar involvement. Whole-exome sequencing was performed on both subjects and revealed a shared hemizygous missense variant (c.A1561G; p.T521A) in exon 15 of PHKA2. The phenotype broadens the clinical and magnetic resonance imaging spectrum of GSD type IXa to include later onset neurological manifestations.

Citing Articles

Mechanisms of Cadmium Neurotoxicity.

Arruebarrena M, Hawe C, Lee Y, Branco R Int J Mol Sci. 2023; 24(23).

PMID: 38068881 PMC: 10706630. DOI: 10.3390/ijms242316558.


Evaluation of Glycogen Storage Patients: Report of Twelve Novel Variants and New Clinical Findings in a Turkish Population.

Ersoy M, Uyanik B, Gedikbasi A Genes (Basel). 2021; 12(12).

PMID: 34946936 PMC: 8701369. DOI: 10.3390/genes12121987.


Profound neonatal lactic acidosis and renal tubulopathy in a patient with glycogen storage disease type IXɑ2 secondary to a pathogenic variant in .

Morales J, Tise C, Narang A, Grimm P, Enns G, Lee C Mol Genet Metab Rep. 2021; 27:100765.

PMID: 34277355 PMC: 8261893. DOI: 10.1016/j.ymgmr.2021.100765.